当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析 - 现金流量表

艾德生物

(300685)

  

流通市值:89.30亿  总市值:89.74亿
流通股本:3.90亿   总股本:3.92亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金556,638,451.47284,254,114.961,118,334,930.68810,767,303.09
  收到其他与经营活动有关的现金20,496,468.246,605,025.4553,556,019.9336,823,496.78
  经营活动现金流入小计577,134,919.71290,859,140.411,171,890,950.61847,590,799.87
  购买商品、接受劳务支付的现金66,363,975.1331,374,465.02154,659,760.55106,409,074.34
  支付给职工以及为职工支付的现金167,322,050.5492,870,145.07311,936,843.36237,964,277.54
  支付的各项税费72,534,139.6121,884,962.0883,867,656.1168,510,242.92
  支付其他与经营活动有关的现金100,331,471.2841,474,715.4279,581,092.51194,424,695.42
  经营活动现金流出小计406,551,636.56187,604,287.57830,045,352.53607,308,290.22
  经营活动产生的现金流量净额170,583,283.15103,254,852.84341,845,598.08240,282,509.65
二、投资活动产生的现金流量:
  收回投资收到的现金200,000,000-580,259,597.92399,901,000
  取得投资收益收到的现金3,395,060.45-14,294,6389,787,603.15
  处置固定资产、无形资产和其他长期资产收回的现金净额--215,728.17-
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计203,395,060.45-594,769,964.09409,688,603.15
  购建固定资产、无形资产和其他长期资产支付的现金30,374,747.2511,256,559.440,207,733.5826,791,738.78
  投资支付的现金204,255,623.45103,454,181.14627,861,577.78413,326,377.78
  投资活动现金流出小计234,630,370.7114,710,740.54668,069,311.36440,118,116.56
  投资活动产生的现金流量净额-31,235,310.25-114,710,740.54-73,299,347.27-30,429,513.41
三、筹资活动产生的现金流量:
  取得借款收到的现金65,000,000---
  收到其他与筹资活动有关的现金129,357.98-249,405-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计65,129,357.98-249,405-
  偿还债务支付的现金44,400,000-7,240,0001,740,000
  分配股利、利润或偿付利息支付的现金93,089,811.38444,00060,592,428.9461,113,072
  支付其他与筹资活动有关的现金35,237,654.1317,234,780.4992,057,336.0889,939,823.22
  筹资活动现金流出小计172,727,465.5117,678,780.49159,889,765.02152,792,895.22
  筹资活动产生的现金流量净额-107,598,107.53-17,678,780.49-159,640,360.02-152,792,895.22
四、汇率变动对现金及现金等价物的影响9,345,925.352,606,466.465,478,078.36-5,173,858.92
五、现金及现金等价物净增加额41,095,790.72-26,528,201.73114,383,969.1551,886,242.1
  加:期初现金及现金等价物余额315,461,835.82315,461,835.82201,077,866.67201,077,866.67
  期末现金及现金等价物余额356,557,626.54288,933,634.09315,461,835.82252,964,108.77
补充资料:
  净利润189,037,382.96-254,863,444.95-
  资产减值准备5,486,930.76-38,368,955.4-
  固定资产和投资性房地产折旧23,507,867.14-44,682,018.11-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,507,867.14-44,682,018.11-
  无形资产摊销3,701,408.44-7,370,642.61-
  长期待摊费用摊销2,026,801.97-3,234,891.03-
  处置固定资产、无形资产和其他长期资产的损失1,759,674.77-1,063,253.41-
  固定资产报废损失-43,497.08-62,049.88-
  公允价值变动损失-3,241,563.21--8,768,533.37-
  财务费用-10,255,253.35-1,906,947.65-
  投资损失-222,855.74-9,254,440.03-
  递延所得税-1,190,183.27--4,811,405.67-
  其中:递延所得税资产减少-1,190,183.27--4,811,405.67-
  存货的减少-7,552,217.17--5,582,833.17-
  经营性应收项目的减少-86,691,916.35--38,356,182.04-
  经营性应付项目的增加52,162,857.41-34,734,992.29-
  现金的期末余额356,557,626.54-315,461,835.82-
  减:现金的期初余额315,461,835.82-201,077,866.67-
  现金及现金等价物的净增加额41,095,790.72-114,383,969.15-
公告日期2025-07-292025-04-222025-04-222024-10-22
审计意见(境内)标准无保留意见
TOP↑